Can Domperidone Be Prescribed During Pregnancy?
Yes, domperidone can be prescribed during pregnancy and is considered compatible across all trimesters according to the most recent high-quality guidelines. The 2023 EASL Clinical Practice Guidelines explicitly list domperidone as compatible with the 1st, 2nd, and 3rd trimesters, as well as with breastfeeding 1.
Guideline-Based Recommendations
The most authoritative guidance comes from the 2023 EASL guidelines on liver diseases in pregnancy, which position domperidone as a second-line treatment for hyperemesis gravidarum 1. This represents the most recent and comprehensive assessment of antiemetic safety in pregnancy.
The 2024 AGA Clinical Practice Update and 2024 BJOG guidelines on nausea and vomiting in pregnancy support this approach, recommending:
- First-line: Antihistamines (cyclizine, promethazine), phenothiazines (prochlorperazine), and pyridoxine-doxylamine 2, 3
- Second-line: Metoclopramide, domperidone, and ondansetron 1, 2
Safety Evidence
Malformation Risk
The reassuring safety data includes:
Large cohort study (13,964 pregnancies): No increased malformation rate with domperidone exposure (adjusted OR = 0.89 [0.77-1.03]) 4. This 2021 French study found that over 75% of exposures occurred in the first trimester with no teratogenic signal.
Japanese cohort (519 pregnancies): Major malformation rate of 2.9% in domperidone-exposed pregnancies versus 1.7% in controls, with no statistically significant difference (adjusted OR: 1.86 [0.73-4.70]) 5.
Prospective study (120 pregnancies): Three malformations in domperidone group versus three in controls (OR = 0.6; 95% CI 0.1,2.8) 6.
Placental Transfer
Animal studies demonstrate that domperidone has limited placental transfer—only 0.2% (IV) to 0.08% (oral) of the maternal dose crosses the placenta, with fetal concentrations 2.1-2.5 times lower than maternal plasma levels 7.
Important Caveats
FDA Status
Critical caveat: Domperidone is not FDA-approved for any indication in humans in the United States 8. The FDA drug label explicitly states it is "not for use in humans" and warns that "pregnant and lactating women should use caution when handling" the veterinary formulation 8. This creates a regulatory barrier in the U.S., though the drug is widely used internationally.
Clinical Context
- Domperidone should be reserved for patients who have failed first-line antiemetics (antihistamines, phenothiazines) 1, 2
- Monitor for extrapyramidal side effects, though these are less common with domperidone than metoclopramide due to limited blood-brain barrier penetration 2
- The drug should be withdrawn if extrapyramidal symptoms occur 2
Practical Prescribing Algorithm
- First attempt: Pyridoxine (vitamin B6), antihistamines (cyclizine, promethazine), or phenothiazines (prochlorperazine)
- If inadequate response: Consider metoclopramide or domperidone as second-line options
- Dosing: Standard doses (typically 10-20 mg three times daily, though not specified in pregnancy guidelines)
- Monitoring: Assess for symptom improvement and any extrapyramidal effects
- Severe refractory cases: Ondansetron or corticosteroids may be considered 1, 2
Bottom Line
Domperidone can be safely prescribed throughout pregnancy based on extensive international guideline support and reassuring observational data showing no increased teratogenic risk. However, U.S. prescribers face regulatory constraints due to lack of FDA approval. In countries where domperidone is available, it represents a reasonable second-line option for nausea and vomiting in pregnancy when first-line agents prove insufficient 1, 4, 5.